S. Scaramuzza

PEG-epirubicin Conjugates with High Drug Loading

F. Veronese, G. Pasut, S. Scaramuzza, 2005 .

Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes

S. Dedoni, P. Onali, S. Genovese, 2012, Results in pharma sciences.

Biophysical Characterization of Met-G-CSF: Effects of Different Site-Specific Mono-Pegylations on Protein Stability and Aggregation

S. Doglia, A. Natalello, G. Chirico, 2012, PloS one.

A new PEG-beta-alanine active derivative for releasable protein conjugation.

F. Veronese, G. Pasut, F. Caboi, 2008, Bioconjugate chemistry.

Generation and testing of engineered multimeric Fabs of trastuzumab.

A. Caporale, M. Ruvo, S. Scaramuzza, 2020, International journal of biological macromolecules.

Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen

M. Ruvo, S. Scaramuzza, G. S. Saccani Jotti, 2016, International journal of molecular sciences.

A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.

P. Caliceti, I. Messana, A. Olianas, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Ultra-performance liquid chromatography/multiple reaction monitoring mass spectrometry quantification of trastuzumab in human serum by selective monitoring of a specific peptide marker from the antibody complementarity-determining regions.

A. Chambery, R. Russo, A. Caporale, 2017, Rapid communications in mass spectrometry : RCM.

UPLC/MRM MS Quantification of Trastuzumab in Human Serum by Selective Monitoring of a Specific Peptide Marker from the Antibody Complementarity-Determining Regions

A. Chambery, R. Russo, A. Caporale, 2017 .

High-level expression of a recombinant active microbial transglutaminase in Escherichia coli

G. Spinetti, S. Scaramuzza, G. S. Saccani Jotti, 2015, BMC Biotechnology.